Comparison of the Effects of Celecoxib, Naproxen and Ibuprofen on Pain Control after Periodontal Surgeries

Message:
Abstract:
Introduction
Effective pain management after dental surgeries is one of the most common problems in dentistry. Ibuprofen is the most common non selective non steroidal anti-inflammatory drug (NSAID), which inhibits both COX-1 and COX-2. Celecoxib is a COX-2 specific NSAID and also the only COX-2 specific drug available in Iran. Naproxen is a non selective NSAID that is often used for postoperative pain management all around the world; however, it is not the first choice in our country. The purpose of this study was to compare the effectiveness of Celecoxib, Naproxen, and Ibuprofen in pain control after periodontal surgery.
Materials and Methods
This double-blind clinical trial study included a total of 30 patients who presented with chronic periodontitis and who underwent surgical procedures on the anterior sextant of the mandible. They were randomly assigned to 3 groups of 10 patients. Each group received one of the following medication protocols: Group A: 400 mg Ibuprofen, group B: 200 mg Celecoxib, Group C: 250 mg Naproxen. Patients reported their pain levels using a VAS (visual analog scale) at 1, 3, 6, 12, 24, and 48 hours after periodontal surgery. All data were analyzed by SPSS Ver 15 program. Data were analyzed using Kruskal-Wallis and Mann-Whitney tests, respectively.
Results
Statistical analysis of the data showed no significant differences between Ibuprofen, Celecoxib, and Naproxen after 1, 6, 12, 24, or 48 hours after the surgery. Significant differences were seen only at the third hour after surgery between Celecoxib and Naproxen and between Ibuprofen and Naproxen.
Conclusion
Considering the lower rate of side effects of Celecoxib its similar degree of pain reduction as Ibuprofen, and its better efficiency than Naproxen, Celecoxib can be considered an appropriate drug for pain control after periodontal surgeries.
Language:
Persian
Published:
Journal of Mashhad Dental School, Volume:35 Issue: 4, 2012
Page:
307
magiran.com/p943371  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!